CDC's hematologic laboratories
conduct research and provide diagnostic services to persons with
certain blood disorders by
-
conducting basic science and
clinical research to define, determine the causes and
complications of, diagnose, and prevent the complications of
blood disorders such as hemophilia and thrombotic disease
-
conducting studies to
evaluate, improve, and standardize methods and procedures for
classifying blood disorders
-
providing diagnostic support
for research studies on emerging diseases
-
maintaining the national
reference laboratory for coagulation disorders and other
hematologic diseases
The Division’s Molecular and
Hemostasis Laboratory Team is organized around two major
activities: cell and molecular investigations, and analysis of
hemostatic proteins.
Cell and molecular laboratory
functions include conducting genetic investigations developing
and adapting new technology and conducting public health and
basic research. Additionally, as part of the lab’s public
health and basic research efforts, laboratory personnel work with
other CDC investigators to determine how infectious agent
contribute to the in vitro procoagulant/inflammatory
phenotype of cells.
The hemostatic protein laboratory is
CLIA-certified; it serves as a reference laboratory and provides
reports to referred patients and study subjects. In addition to
providing support for the Division’s epidemiologic studies and
CDC outbreak investigations, the laboratory conducts research on
von Willebrand disease, bleeding disorders of women, adverse
pregnancy outcome, and translation of research findings into
diagnostic tests.
[Return to top]
Date: November 21, 2005
Content source: National Center on Birth Defects and Developmental
Disabilities